Carcinoembryonic antigen (CEA), first identified in the plasma of patients with colonic adenocarcinoma (Gold and Freedman, 1965a) and initially believed to be a specific product of fetal gut and of tumours of endodermal origin (Gold and Freedman, 1965b) , is now known to be present in the plasma of individuals with a wide range of benign and malignant conditions (Lo Gerfo et al., 1971; Reynoso et al., 1972; Pusztaszeri and Mach, 1973; Hansen et al., 1974) . There have been a number of reports of elevated plasma CEA levels in women with ovarian neoplasms (Khoo and Mackay, 1973; van Nagell etal., 1975a van Nagell etal., , 1975b DiSaia et al., 1975; Barrelet and Mach, 1975; Samaan et al., 1976; Puri et al., 1977) but the more recently introduced immunoperoxidase method for the demonstration of CEA in tissue sections (Primus et al., 1975; Goldenberg et al., 1976; Isaacson and Le Vann, 1976; Heyderman and Neville, 1977) has not been extensively applied to ovarian tumours. Marchand et al. (1975) , using this technique, were unable to detect any CEA in serous tumours and demonstrated this antigen only in those mucinous neoplasms in which the epithelium was of the 'intestinal' type while van Nagell et al. (1978) , who studied 88 ovarian carcinomas, found CEA in 21 % of those of mucinous type and in only 2% of the serous tumours. Rutanen et al. (1978) could, by contrast, detect no CEA in any of the 12 ovarian Received for publication 31 January 1979 carcinomas that they studied though the antigen was present in two of seven mucinous cystadenomas.
The present study was undertaken partly because of the discrepancies in these previous reports and partly to attempt to answer two specific questions: (i) Is the presence of CEA in an ovarian epithelial neoplasm dependent upon, or related to, the specific nature of the tumour epithelium, its presence or absence being thus of value in the differential histological diagnosis of this group of neoplasms? (ii) In epithelial tumours of the ovary, in which there is a continuous spectrum from fully benign to frankly malignant, is there any correlation between the degree of malignancy of any particular neoplasm and its tissue content of CEA?
Material and methods
Formalin-fixed, paraffin-processed tissue from specimens received in the pathological laboratory at St Mary's Hospital, Manchester were used in this study. The series comprised 82 epithelial neoplasms of the ovary (Table) , and in each case eosin and haematoxylin stained sections were examined and a consensus histological diagnosis was agreed, using for this purpose the criteria laid down by the World Health Organisation (Serov and Scully, 1973) . Mucinous tumours were also stained by Bodian's protargol method and those which contained argyrophil cells were classed as being of 'intestinal' type (Fox et al., 1964) . 918 Serial 5 /tm sections were cut from each block of tissue and treated with anti-CEA serum to determine the highest dilution at which staining could be detected. All the antisera used were commercially prepared (Dakopatts), and for the demonstration of CEA a modification of the unlabelled antibody enzyme (PAP) method (Sternberger et al., 1970) was used. Sections were dewaxed in xylene and then submerged in a 1 % solution of 100 volume hydrogen peroxide in methanol for 45 minutes to abolish endogenous peroxidase activity. The non-specific background staining was reduced by treating the sections with non-immune non-conjugated swine serum in buffer at a dilution of 1 in 5 for 5 minutes; it was further reduced by bringing all the antisera to the required dilution in a 1 in 20 solution of swine serum in buffered saline. The non-immune swine serum was tipped off the slides and the sections were wiped, but not washed, before the appropriate dilution of rabbit anti-CEA antiserum was applied for 45 minutes. The sections were then treated with a 1 in 20 dilution of swine anti-rabbit-IgG antiserum for 15 minutes followed by a 1 in 60 dilution of rabbit peroxidase-antiperoxidase antiserum for 15 minutes. After each of the three stages the sections were rinsed briefly with two changes of tris buffered saline and then washed for 5 minutes over a magnetic stirrer. The staining was developed for 5 minutes in a freshly prepared solution of 0035% w/v diaminobenzidine tetrahydrochloride (Sigma) and 0-01 % w/v hydrogen peroxide in tris buffered saline (Graham and Karnovsky, 1966) . Finally, the sections were washed in running water for 5 minutes, weakly counterstained with Harris's haematoxylin, de- hydrated, and mounted.
Control sections of tumour tissue were treated with anti-CEA antiserum conjugated with purified CEA (British Standards Institute), and this resulted in complete abolition of staining (Figs la and I b), as did also the substitution of non-immune rabbit serum for the specific anti-CEA antiserum. As a positive control, sections of a colonic adenocarcinoma known to contain CEA were stained.
Results
Staining of the cell surface or the glycocalyx was observed in a number of tumours but it was found that more consistent and easily assessed results were obtained if only the cytoplasmic reaction was evaluated. This also eliminated the difficulty of deciding whether stained material in a glandular lumen lay truly within the lumen or in the glycocalyx.
In tumours showing a positive reaction for CEA there was commonly a diffuse, uniform cytoplasmic staining of the cells containing this substance ( Figs  2 and 3) ; in some cells, however, staining was concentrated in either the apical (Fig. 4) or basal (Fig. 5 ) regions while in a proportion of the mucinous neoplasms the staining was limited to the perinuclear cytoplasm (Fig. 6 ).
MUCINOUS TUMOURS (Fig. 7) These were stained with the primary antiserum in dilutions ranging from 1 in 100 to 1 in 4000. A positive reaction was obtained in only three (30 %) of the benign mucinous cysts, even at the lowest dilution of antiserum (1 in 100); within this group no staining was seen at a dilution of 1 in 800. By comparison, all mucinous tumours of borderline malignancy showed some degree of positive staining at dilutions of 1 in 100, though at dilutions greater than this the proportion of borderline tumours giving a positive reaction decreased progressively; nevertheless, at a 1 in 4000 dilution 45 % still stained positively. In this group of tumours of borderline malignancy CEA was present in both the obviously proliferating areas and in those areas showing no atypical features.
All the mucinous carcinomas stained positively at a dilution of 1 in 3000, and at a dilution of 1 in 4000 a positive reaction was still obtained in 78%; no. correlation was apparent between the tissue content of CEA and the degree of differentiation in this. malignant group of neoplasms.
Mucinous tumours of 'intestinal' type were represented in the benign, borderline, and malignant groups, and these could not be separated out on the basis of their content of CEA, such neoplasms showing a staining pattern identical with those of non-intestinal type.
SEROUS TUMOURS (Fig. 8 The remaining 20 % of the malignant serous tumours continued to show marked staining up to a dilution of 1 in 1000, but at dilutions beyond this the staining was scanty and focal. As with the mucinous group of neoplasms those serous tumours considered to be of borderline malignancy stained positively for CEA both in the overtly proliferating epithelium and in that showing no atypical features. The serous carcinomas that lacked a content of CEA did not differ in any morphological manner, or in their degree of differentiation, from those which stained positively for this antigen.
ENDOMETRIOID TUMOURS
All 12 endometrioid tumours studied were malignant, and in these only the adenocarcinomatous areas were considered, staining in foci of metaplastic squamous epithelium being excluded. Three of the endometrioid tumours appeared to be devoid of CEA while the remaining nine showed no staining with antiserum dilutions of 1 in 1000 or greater.
MESONEPHROID TUMOURS
One mesonephroid tumour was completely negative, and another stained only focally, at a dilution of 1 in 100. The other two neoplasms in this category stained at higher dilutions of the primary antiserum, one still giving a positive reaction for CEA at a dilution of 1 in 4000.
Discussion
The first of the two questions posed at the outset of this study is readily answered. The synthesis of CEA is not a prerogative of any particular or specific variety of ovarian epithelial tumour and hence the presence of this antigen in a neoplasm of this type is of little value in differential histological diagnosis. It is true that serous tumours contain less CEA than do their mucinous counterparts but confusion between these two entities is uncommon and the frequently encountered diagnostic difficulty, that of differentiating serous from. endometrioid or mesonephric neoplasms, appears unlikely to be resolved by a study of tissue CEA content. It is also disappointing to note that the CEA content of a mucinous tumour was independent of the nature of the epithelium, appearing in similar quantities in both 'intestinal' and 'non-intestinal' type neoplasms.
The relationship between the degree of malignancy in epithelial ovarian tumours and their tissue CEA content is more difficult to evaluate. In mucinous tumours it is clear that, in general, malignant neoplasms contain considerably more CEA than do removed before histological evidence of this potentiality for atypical growth had become apparent. A significant proportion of the borderline group of mucinous tumours has a tissue CEA content which approximates to that found in frankly malignant tumours, and, applying the same arguments pursued above, it could be suggested that these neoplasms are already committed to become overtly malignant though as yet lacking all the histological criteria for the diagnosis of carcinoma. In this series, follow-up of the patients withborderline tumourswas unsatisfactory and certainly inadequate to furnish any evidence either for or against this suggestion which can only be tested in a prospective study of a large series of patients with borderline tumours.
In the serous group of neoplasms the findings are less open to interpretation, speculative or otherwise. About the only conclusion that can be drawn from a study of tissue CEA content in this group of tumours is that a serous neoplasm containing CEA is probably malignant; the reverse contention, that tumours lacking CEA are therefore benign, is one that can not, however, be sustained.
